TOP SELLING PRODUCTS IGF-1 LR3 1MG is a research peptide referenced in scientific literature as a synthetic analogue of insulin-like growth factor 1
David Chandy, director, endocrinology and diabetology, Sir H.N
Long-term safety beyond 12 weeks has not been formally studied in large populations
This preserves the peptides integrity and potency for the duration of your research protocol
By improving metabolic regulation, moderating nutrient signaling, and reducing chronic inflammatory burden, these therapies may help alleviate physiological stress that contributes to age-related disease and functional decline
Instead, it works gradually, with noticeable changes typically appearing within 4 to 6 weeks